    Sentence 1: About 18 percent of men  taking finasteride developed prostate  cancer , compared with 24 percent on  placebo.    Sentence 2: They found that 6.4  percent of men on finasteride had  high-grade tumors , compared to 5.1  percent taking a placebo.    